class 4 yana Flashcards

1
Q

Describe the metastatic cascade in cancer progression.

A

The metastatic cascade involves tumour cells escaping the primary site, invading surrounding tissue, intravasating into blood or lymphatic vessels, circulating, extravasating at a distant site, and forming a metastatic tumour.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How do immune cells like CD8+ T cells and NK cells restrict the metastatic outgrowth of cancer cells?

A

They recognize and restrict the growth of mutant and potentially immunogenic tumour cells during the metastatic cascade.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define pre-metastatic niche in the context of cancer metastasis.

A

It refers to the environment of the future metastatic site, which is remotely prepared by tumour cells at the primary site.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What role do myeloid cells, particularly macrophages, play in the metastatic process?

A

They actively participate in metastatic processes and facilitate the escape of circulating metastatic cells from immune detection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the systemic enhancements of metastasis driven by primary tumours.

A

They involve myeloid cells that prepare distant sites to become pre-metastatic niches, thereby enhancing metastatic efficiency and altering haematopoiesis in the bone marrow.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the role of chemokines and cytokines in the recruitment of immune cells in the primary tumour.

A

Chemokines and cytokines are secreted by cancer cells to recruit tumour-associated macrophages (TAMs), tumour-associated neutrophils (TANs), myeloid-derived suppressor cells (MDSCs), and regulatory T (TReg) cells, which directly suppress the cytotoxic functions of natural killer (NK) cells and CD8+ T cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the systemic factors produced by the primary tumour, and how do they contribute to the metastatic process?

A

The primary tumour produces systemic factors such as vascular endothelial growth factor A (VEGFA), TGFβ, tumour necrosis factor (TNF), and lysyl oxidase (LOX), which induce chemotactic protein expression and extracellular matrix remodelling in the metastatic sites before tumour cell arrival.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Define the function of immature myeloid cells in the pre-metastatic niche.

A

Immature myeloid cells are recruited to the pre-metastatic niche and form clusters, secreting matrix metalloproteinase 9 (MMP9) to promote the subsequent outgrowth of metastasizing cancer cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do TAMs and TReg cells contribute to future metastasis in the pre-metastatic niche?

A

TAMs and TReg cells are recruited to the pre-metastatic niche by primary tumour-derived fibrin clots, CCL2, and CCL22, and these cells promote future metastasis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe tumour-associated macrophages (TAMs and their marker profile.

A

TAMs are a distinct population of macrophages in the tumour microenvironment that promote tumour development and progression. They can be identified by markers such as CD11b, CD14, CD23, CD68, CD163, CD204, and others.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are myeloid-derived suppressor cells (MDSCs) and how are they subdivided?

A

MDSCs are a heterogeneous population of myeloid cells increased in cancer patients. They are subdivided into monocytic and granulocytic MDSCs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Define plasmacytoid dendritic cells (pDCs) and their characteristics.

A

pDCs are a small population of dendritic cells that link innate and adaptive immune responses. They have pro-inflammatory properties and immunosuppressive effects, characterized by expression of B220, CD11c, Siglec-H, PDCA1, and GR1.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Explain osteoclastogenesis.

A

Osteoclastogenesis is the process where haematopoietic stem cells differentiate into multinucleated osteoclasts with bone-resorbing activity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How do cancer-associated fibroblasts contribute to the immunosuppressive function of immature myeloid cells?

A

They secrete granulocyte colony-stimulating factor (G-CSF), which promotes the immunosuppressive function of immature myeloid cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe metastasis-associated macrophages (MAMs) and their role in tumour progression.

A

MAMs are a distinct subset of tumour-associated macrophages recruited to metastatic sites, promoting tumour cell dissemination and outgrowth. They originate from inflammatory monocytes and are characterized by specific marker profiles.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do myeloid progenitor cells contribute to the establishment of the pre-metastatic niche?

A

Myeloid progenitor cells are the central cell population that establishes the pre-metastatic niche. They are recruited by primary tumour-derived factors and can rapidly differentiate into metastasis-associated macrophages (MAMs) at pre-metastatic sites, enhancing tumour cell extravasation and survival.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Define tumour cell egress and explain the role of myeloid cells in this process.

A

Tumour cell egress refers to the migration of tumour cells from the primary site through the stroma and intravasation into blood vessels. Myeloid cells, such as TAMs and TANs, contribute to these early steps of metastasis by promoting tumour intravasation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe the contribution of macrophages to tumour progression and metastasis.

A

Ablation of macrophages impairs the onset of angiogenesis and suppresses lung metastases, indicating their significant contribution to tumour progression and metastasis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How do CD4+ T cells contribute to the process of tumour cell egress?

A

CD4+ T cells contribute to tumour cell egress through the modulation of macrophage phenotypes, although direct involvement of lymphocytes in tumour cell egress has not been reported.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Describe the role of histidine-rich glycoprotein in cancer cells.

A

Histidine-rich glycoprotein in cancer cells skews TAM polarization from a pro-tumorigenic to a tumour-inhibiting phenotype by downregulating placental growth factor (PGF) expression, which normalizes the leaky blood vessels and inhibits metastasis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the function of TAMs in the tumor microenvironment?

A

TAMs (tumor-associated macrophages) are polarized from a tumour-reactive to a tumour-promoting state, contributing to the pro-metastatic function of TAMs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Define the process of TAM polarization in the tumor microenvironment.

A

The tumor microenvironment polarizes recruited macrophages from a tumour-reactive to a tumour-promoting state, which can be suppressed by targeting signaling pathways that regulate TAM polarization.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

How does the interaction between cancer cells and TAMs contribute to tumor metastasis?

A

The interaction between cancer cells and TAMs leads to the promotion of the first step of metastasis, including tumour angiogenesis, invasion, and intravasation, ultimately facilitating haematogenous dissemination of cancer cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Describe the ‘tumour microenvironment forasis’ (TMEM) and its association with breast cancer metastasis.

A

The TMEM refers to the direct contact between perivascular TAMs, endothelial cells, and tumor cells, and a high TMEM score is associated with an increased risk ofasis in human breast cancer specimens.

25
Q

What is the role of neutrophils in tumor metastasis?

A

Neutrophils can promote tumor metastasis by increasing angiogenesis and intravasation of cancer cells through the secretion of MMP9, and by promoting lung metastasis of cancer cells through recruitment and other mechanisms.

26
Q

How do TAMs accelerate tumor intravasation and increase the risk of systemic tumor cell dissemination?

A

The interaction between perivascular TAMs and tumor cells accelerates tumor intravasation, thereby increasing the risk of systemic tumor cell dissemination.

27
Q

Define MENA and its role in breast cancer metastasis.

A

MENA is the invasion isoform of vasodilator-stimulated phosphoprotein, and its expression strongly potentiates EGF signaling in cancer cells, and is required for macrophage-induced in vitro intravasation of human breast cancer cells.

28
Q

Describe the role of CD11b+ macrophages in tumour cell survival and clot formation.

A

CD11b+ macrophages play a role in promoting tumour cell survival by transmitting survival signals to cancer cells via VCAM1, which increases lung metastasis. They also contribute to clot formation by being recruited after tumour-initiated clot formation.

29
Q

How do LY6C+ monocytes contribute to tumour cell survival at metastatic sites?

A

LY6C+ monocytes, progenitor cells of macrophages in metastatic sites, are recruited via selectin ligand-mediated recruitment and contribute to efficient tumour cell survival at the metastatic site.

30
Q

Define the role of TReg cells at metastatic sites in protecting disseminated cancer cells from immune responses.

A

TReg cells at metastatic sites protect disseminated cancer cells from immune responses by inhibiting proliferation and cytokine production of CD4+ and CD8+ T cells, as well as by secreting RANKL, which activates its receptor RANK on cancer cells and promotes lung metastasis.

31
Q

What is the significance of CD47 and hepatocyte growth factor receptor (HGFR) in circulating tumour cells from patients with breast cancer?

A

CD47 and HGFR in circulating tumour cells can inhibit phagocytosis by innate immune cells, contributing to the survival of malignant cells and their ability to initiate metastatic foci in mice.

32
Q

Describe the sequential pathway of clot formation and macrophage recruitment in the context of tumour cell survival.

A

Clot formation and macrophage recruitment occur sequentially in a linear pathway, where tumour-initiated clot formation activates endothelial cells to recruit macrophages, which then transmit survival signals to cancer cells, contributing to lung metastasis.

33
Q

Describe the characteristics of inflammatory monocytes in mice and humans.

A

In mice, inflammatory monocytes are characterized as CD11b+LY6C+, while in humans they are characterized as CD14hiCD16−.

34
Q

What is the major function of neutrophil extracellular traps (NETs)?

A

The major function of NETs is to trap and kill pathogens.

35
Q

Define extravasation in the context of metastatic growth.

A

Extravasation refers to the process by which arrested tumour cells exit the bloodstream and grow at distant sites.

36
Q

How do macrophages, neutrophils, and platelets contribute to the metastatic steps following tumour egress?

A

They have been reported to promote the inefficient steps of metastasis, including survival, extravasation, and metastatic growth.

37
Q

Describe the characteristics of metastasis-associated macrophages (MAMs) in the lungs of PyMT mice.

A

MAMs are characterized by the expression of CD11b, VEGF receptor 1 (VEGFR1), CXC-chemokine receptor 3 (CXCR3), and CC-chemokine receptor 2 (CCR2), and by the absence of GR1, angiopoietin 1 receptor (TIE2), and CD11c.

38
Q

Describe the role of platelets in the process of metastatic seeding.

A

Platelets arrest tumor cells in capillaries and provide a survival signal, allowing a chemotactic gradient of CCL2 to be established to recruit inflammatory monocytes.

39
Q

Define MAMs and their role in metastatic seeding.

A

MAMs are monocytes that differentiate into macrophages and promote extravasation and cancer cell survival through cell-to-cell contact during metastatic seeding.

40
Q

How have recent advances in anti-tumor therapy targeted pro-metastatic immune cells?

A

Recent advances have focused on augmenting tumoricidal T cell responses, neutralizing inhibitory receptors such as CTLA4 and PD1, and inhibiting TReg cells and MDSCs through inactivation of p110δ isoform of PI3Kδ.

41
Q

Do antibodies against CTLA4 or PD1 have clinical significance in cancer treatment?

A

Yes, antibodies against CTLA4 or PD1 have been clinically tested and have resulted in prolonged overall survival of patients with cancer.

42
Q

Describe the potential therapeutic effect of idelalisib in cancer treatment.

A

Idelalisib, a selective PI3Kδ inhibitor, has shown tolerance and effectiveness in patients with chronic lymphocytic leukemia, although its therapeutic effect on metastatic disease has not been tested yet.

43
Q

Describe the effect of CCR2 antibody (MLN1202) in the clinical trial.

A

The antibody reduced the levels of urinary N-telopeptide of type I collagen, a marker of bone resorption induced by metastatic cancer cells, in 14 out of 43 patients with bone metastases.

44
Q

What is the mechanism of action of trabectedin (Yondelis) in modulating TAM recruitment?

A

Trabectedin modulates TAM recruitment by inhibiting CCL2 expression.

45
Q

Define the potential consequence of ceasing CCL2-specific treatment based on the mouse model study.

A

Cessation of CCL2-specific treatment in a mouse model caused an influx of monocytes into metastatic sites, enhancing local angiogenesis and metastatic outgrowth, thereby increasing mortality.

46
Q

How might targeting specific components of the immune system result in less toxicity compared to blocking inhibitory receptors such as CTLA4?

A

Targeting specific components of the immune system might result in less toxicity than blocking inhibitory receptors such as CTLA4 on all cells that express this receptor, which could result in increased autoimmune responses.

47
Q

Describe the potential therapeutic strategy suggested by the observed suppressive effects in the mentioned studies.

A

The observed suppressive effects suggest that a macrophage-targeting therapy may be an effective strategy, and combining conventional therapeutic modalities with immunotherapy and macrophage-modulating therapy may lead to effective therapeutic strategies to control or eliminate metastatic disease.

48
Q

Describe the concept of tumor immune surveillance and immune escape.

A

Tumor immune surveillance refers to the immune system’s ability to recognize and eliminate tumor cells, while immune escape involves mechanisms by which tumor cells evade immune detection and destruction.

49
Q

Define the role of natural killer cells in preventing cancer metastasis.

A

Natural killer cells play a crucial role in limiting cancer metastasis by targeting and destroying circulating tumor cells.

50
Q

How do tumor-associated macrophages contribute to cancer progression and metastasis?

A

Tumor-associated macrophages promote cancer progression and metastasis by creating an immunosuppressive microenvironment, facilitating angiogenesis, and promoting tumor cell invasion and migration.

51
Q

Do tumor-infiltrating immune cells have a potential link to conventional cancer therapy and immunity?

A

Yes, tumor-infiltrating immune cells may have a potential link to conventional cancer therapy and immunity, influencing treatment responses and patient prognosis.

52
Q

Describe the findings of the study by Chittezhath et al. regarding monocytes and macrophages in human cancer progression.

A

The study revealed a tumor-promoting phenotype of monocytes and macrophages in human cancer progression.

53
Q

Define the positive feedback loop between mesenchymal-like cancer cells and macrophages as described in the study by Su et al.

A

The positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis.

54
Q

How does HRG inhibit tumor growth and metastasis according to the study by Rolny et al.?

A

HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF.

55
Q

Do macrophages play a role in tumor cell migration, invasion, and metastasis according to the study by Condeelis and Pollard?

A

Yes, macrophages are described as obligate partners for tumor cell migration, invasion, and metastasis.

56
Q

Describe the role of neutrophils and neutrophil TIMP-free MMP-9 in regulating tumor angiogenesis and malignant cell intravasation as discussed in the study by Bekes et al.

A

Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation.

57
Q

How does CXCL5 contribute to tumor metastasis and recurrence of intrahepatic cholangiocarcinoma according to the study by Zhou et al.?

A

CXCL5 contributes to tumor metastasis and recurrence of intrahepatic cholangiocarcinoma by recruiting infiltrative intratumoral neutrophils.

58
Q

Describe the impact of ultraviolet-radiation-induced inflammation on promoting angiotropism and metastasis in melanoma as discussed in the study by Bald et al.

A

Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma.

59
Q

How does abrogation of TGFβ signaling in mammary carcinomas affect metastasis according to the study by Yang et al.?

A

Abrogation of TGFβ signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis.